We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$52.8B
AUM Growth
+$12.4B
(+31%)
Cap. Flow
+$6.6B
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
10.83%
Holding
4,679
New
953
Increased
1,510
Reduced
1,399
Closed
740
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$763M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$336M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$246M |
| 4 |
Apple
AAPL
|
+$203M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$158M |
| 2 |
Sherwin-Williams
SHW
|
+$155M |
| 3 |
Goldman Sachs
GS
|
+$139M |
| 4 |
Bank of America
BAC
|
+$127M |
| 5 |
Royal Caribbean
RCL
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.3% |
| 2 | Consumer Discretionary | 7.9% |
| 3 | Healthcare | 4.86% |
| 4 | Financials | 4.75% |
| 5 | Industrials | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCON
3801
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $72.2K | ﹤0.01% |
+20,614
| New | +$72.5K |
|
3802
NextDecade
NEXT
$1.85B
| $72.1K | ﹤0.01% |
15,123
-100,923
| -87% | -$470K |
|
|
ORGN
3803
DELISTED
Origin Materials
ORGN
| $71.2K | ﹤0.01% |
2,837
-24,264
| -90% | -$696K |
|
3804
Aemetis
AMTX
$119M
| $70.7K | ﹤0.01% |
+13,498
| New | +$63.8K |
|
3805
Scilex Holding
SCLX
$48.1M
| $70.6K | ﹤0.01% |
988
-2,016
| -67% | -$105K |
|
3806
OppFi
OPFI
$770M
| $70.3K | ﹤0.01% |
+13,738
| New | +$43.8K |
|
|
URG
3807
Ur-Energy
URG
$485M
| $70.3K | ﹤0.01% |
+45,643
| New | +$70.8K |
|
|
JMIA
3808
CALL
Jumia Technologies
JMIA
$726M
| $69.9K | ﹤0.01% |
+19,800
| New | +$59.5K |
|
3809
Gaotu Techedu
GOTU
$372M
| $69.4K | ﹤0.01% |
19,170
-45,450
| -70% | -$128K |
|
3810
Sportsman's Warehouse
SPWH
$43.7M
| $68.7K | ﹤0.01% |
+16,128
| New | +$76.5K |
|
3811
Inogen
INGN
$167M
| $68.5K | ﹤0.01% |
+12,482
| New | +$66K |
|
3812
Conduent
CNDT
$230M
| $68.3K | ﹤0.01% |
+18,706
| New | +$59.2K |
|
|
OPTU
3813
Optimum Communications Inc
OPTU
$316M
| $66.7K | ﹤0.01% |
20,523
-148,212
| -88% | -$388K |
|
3814
Purple Innovation
PRPL
$33.2M
| $66K | ﹤0.01% |
+2,563
| New | +$65.7K |
|
3815
SCYNEXIS
SCYX
$37M
| $65.9K | ﹤0.01% |
+3,696
| New | +$54.2K |
|
3816
Porch Group
PRCH
$1.3B
| $65.1K | ﹤0.01% |
+21,140
| New | +$29.7K |
|
3817
Vuzix
VUZI
$190M
| $65.1K | ﹤0.01% |
+31,227
| New | +$85.1K |
|
3818
Ranpak Holdings
PACK
$553M
| $64.9K | ﹤0.01% |
11,151
-133,892
| -92% | -$566K |
|
3819
PDS Biotechnology
PDSB
$38.1M
| $64.7K | ﹤0.01% |
13,011
+1,935
| +17% | +$9.62K |
|
|
PHLT
3820
DELISTED
Performant Healthcare Inc
PHLT
| $64.6K | ﹤0.01% |
20,661
+5,042
| +32% | +$13.2K |
|
|
AWH
3821
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $62.7K | ﹤0.01% |
+15,365
| New | +$62.6K |
|
3822
PUT
ChargePoint
CHPT
$133M
| $62.2K | ﹤0.01% |
1,330
-20,445
| -94% | -$1.14M |
|
3823
Ocular Therapeutix
OCUL
$1.86B
| $62.2K | ﹤0.01% |
+13,944
| New | +$41.2K |
|
3824
Pixelworks
PXLW
$38.8M
| $60.9K | ﹤0.01% |
3,872
+1,061
| +38% | +$15.4K |
|
3825
Aveanna Healthcare
AVAH
$2.06B
| $60.1K | ﹤0.01% |
22,437
+7,618
| +51% | +$14.5K |
|
Similar funds
Squarepoint's Q4 2023 Portfolio in Review
As of Q4 2023, Squarepoint held 4,679 positions worth $52.8B, up 31% from $40.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $6.6B of net new capital in Q4 2023, opening 953 new positions and adding to 1,510 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Intuit, an estimated $158M trimmed.
- Squarepoint's largest Q4 2023 buy was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $763M increase.
- Squarepoint's biggest Q4 2023 reduction was Intuit, cutting an estimated $158M.
- Squarepoint fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2023, selling an estimated $97.9M.
- Squarepoint's ten largest holdings make up 11% of its $52.8B portfolio in Q4 2023.
- Squarepoint opened 953 new positions and closed 740 in Q4 2023.
- Squarepoint's portfolio value rose 31% quarter-over-quarter to $52.8B.
Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.